ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer

Автор: PeerView Oncology

Загружено: 2024-01-02

Просмотров: 1519

Описание: This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/GHA865. CME/MOC/AAPA credit will be available until January 6, 2025.
Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer: Risk Assessment, Prognostic Testing, and Selection and Sequencing of Therapies
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

TROP2-Targeting ADCs in the Forefront of Triple-Negative and HR+, HER2- Breast Cancer Care

TROP2-Targeting ADCs in the Forefront of Triple-Negative and HR+, HER2- Breast Cancer Care

Highlights of the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD

Highlights of the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD

Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers

Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy

Guiding Multifactorial Clinical Decisions in HR+, HER2- Breast Cancer

Guiding Multifactorial Clinical Decisions in HR+, HER2- Breast Cancer

Tamoxifen & Aromatase Inhibitors: How to Tolerate them for best results!

Tamoxifen & Aromatase Inhibitors: How to Tolerate them for best results!

Основные моменты SABCS 2023 HER2+ рака молочной железы – субанализ APHINITY, обновление KATHERINE...

Основные моменты SABCS 2023 HER2+ рака молочной железы – субанализ APHINITY, обновление KATHERINE...

Defining  Our Treatment Goals: Raising the Bar in PBC Management Podcast

Defining Our Treatment Goals: Raising the Bar in PBC Management Podcast

Updates in Systemic Therapy for Breast Cancer 2/8/23

Updates in Systemic Therapy for Breast Cancer 2/8/23

Decreasing my Cancer Med Dose - Verzenio/Abemaciclib | Quality vs. Quantity of Life

Decreasing my Cancer Med Dose - Verzenio/Abemaciclib | Quality vs. Quantity of Life

SABCS 2022: Results from the Phase III CAPItello-291 trial

SABCS 2022: Results from the Phase III CAPItello-291 trial

ИНВАЛИДНОСТЬ начинается со СТОП (95% не обращают внимание на это)

ИНВАЛИДНОСТЬ начинается со СТОП (95% не обращают внимание на это)

Catalysts for Enhanced Patient CARE In Neuroendocrine Neoplasm

Catalysts for Enhanced Patient CARE In Neuroendocrine Neoplasm

Breast Cancer Breakout: Rapid research developments and new treatment combinations

Breast Cancer Breakout: Rapid research developments and new treatment combinations

Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference

Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference

Streamlining Multidirectional Care in HCC

Streamlining Multidirectional Care in HCC

Is Organ Preservation for GEJ and Gastric Cancers Ready for Primetime?

Is Organ Preservation for GEJ and Gastric Cancers Ready for Primetime?

CDK4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in HR-positive/HER2-nega...

CDK4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in HR-positive/HER2-nega...

Report Back from SGO 2023: What’s New in Uterine Cancer?

Report Back from SGO 2023: What’s New in Uterine Cancer?

Setting Our Sights on Symptom Management: Raising the Bar in PBC Management Podcast

Setting Our Sights on Symptom Management: Raising the Bar in PBC Management Podcast

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]